The aim of our study was to assess the interplay between circulating CD169+ monocytes and DCs, which are part of the monocyte–phagocyte system and key players in the modulation of the immune-inflammatory process against viral infections [12,25], in a cohort of patients hospitalized for COVID-19 pneumonia. Here, SIGLEC1 is linked to viral infectious disease.